CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 343 participants.

Also called NCT03455725

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 343 participants (planned count) (from the registry)
Sponsor
BioCardia, Inc. (from the registry)
Registry
  • NCT NCT03455725
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03455725. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-30 (actual); primary completion 2025-02-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
Acronym
CardiAMP-CMI
Condition
Refractory Angina
Condition
Chronic Myocardial Ischemia
Intervention (Device)
CardiAMP Cell Therapy System
Intervention (Other)
Sham Treatment
Lead sponsor
BioCardia, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03455725
Content hash
798fb1d462dcdd14597b741b544a47425a6a2bb0f8296355e09caed8246858bf